Patients with chronic obstructive pulmonary disease (COPD) are unable to do physical exercises included into standard pulmonary rehabilitation programs. Neuromuscular electrical stimulation (NMES) is a good alternative for such patients as it does not aggravate shortness of breath. The aim of this work was to assess the effect of short-term NMES of the quadriceps femoris muscle on the physical activity of patients with COPD. Our prospective open randomized study was carried out in 36 patients distributed into two groups. The main group was administered NMES for 10 days. On day 10 clinical and functional parameters, as well as adverse events, were evaluated. On admission to hospital, the groups did not differ in terms of the studied parameters. Following the treatment course, the main group significantly improved their step count and electromyography results (418.5 (86.0; 815.0) vs. 226.7 (48.0; 660.0), p = 0.02, and 463.0 (122; 804) vs. 210.5 (64; 481), p = 0.0001, respectively). The patients scored much less on the Mmrc and Borg scales and the CAT-test: 22.8 (18.0; 34.0) vs. 28.4 (26.0; 34.0), p = 0.00007; 2.7 (2.0; 4.0) vs. 3.1 (3.0; 4.0), p = 0.03; and 6.3 (5.0; 7.0) vs. 7.2 (6.0; 9.0), p = 0.0002, respectively. No adverse events were registered in the main group. Based on the obtained results, we conclude that shortterm NMES of the quadriceps femoris muscle improves physical activity, the quality of life and ability to do physical exercise in patients with COPD providing them with a good alternative to standard rehabilitation programs.
VIEWS 4164
Natural non-pathogenic and vaccine strains of human enteroviruses are currently considered as promising agents capable of treating various kinds of cancer, including glioblastoma multiforme, the most aggressive brain tumor with so far no effective therapy. Enteroviruses can selectively replicate in cancer cells and cause tumor lysis. However, the ability of enteroviruses to persist in tumor tissue for a long period of time and to replicate in several successive cycles while spreading from cell to cell remains largely unclear. This study aimed to determine the possibility of completely destroying subcutaneous mouse xenografts of human glioblastomas through a single intravenous administration of virus-carrying peripheral blood leukocytes, as well as to find out the duration of persistence of the virus in the body of experimental animals in the context of viral therapy. Neurospheres were formed in vitro by incubating fragments of patients-derived glioblastomas and used to initiate subcutaneous tumors in immunodeficient mice. It was established that human peripheral blood leukocytes infected in vitro can effectively deliver Coxsackie A7 virus to the tumor cells. A single injection of 2 × 104 virus-infected leukocytes led to a gradual regression of tumors, while the virus presence was constantly detectable in the blood of mice, up to the complete regression of the tumors. The study allows to make the conclusion that blood leukocytes can effectively deliver Coxsackie A7 virus to the tumor. In the absence of a full-fledged immune response in mice, the viruses persist in tumors leading to their complete destruction.
VIEWS 4485
Introduced into clinical practice in 2011, non-invasive prenatal testing (NIPT) allows detection of chromosomal aneuploidies in the fetus using maternal blood samples. Multiple studies have shown that one of the key factors affecting the result of this test is the fetal DNA fraction. The aim of this work was to develop a method capable of measuring the fetal DNA fraction based on targeted SNP sequencing. We selected polymorphisms with high frequency of heterozygous genotype from the international HapMap database. To estimate the frequency of these polymorphisms in the Russian population, we used 827 DNA donor samples. Fetal DNA fraction was measured in 87 plasma samples of pregnant women. Sequencing was performed on Ion Proton and Ion S5. We determined the frequencies of the studied polymorphisms in the pooled samples and compared the data on 53 SNPs in the pooled and 87 individual samples. The median difference was 3.4%. The correlation between the results obtained by targeted SNP sequencing and Y chromosome read count was 0.7. Thus, the proposed method can be used to estimate the fetal DNA fraction using SNP genotyping regardless of the fetus’s sex.
VIEWS 3877
Nitric oxide has a significant role in the pathogenesis of bronchial asthma and hypertension. Its synthesis is catalyzed by NO synthases. The nucleotide composition of genes coding for these enzymes can affect their activity; therefore, it is important to understand the effect of the NOS3 786C/T polymorphism (rs2070744) on the blood levels of nitric oxide in patients with bronchial asthma and hypertension. Our study recruited 71 individuals. The main group consisted of 24 asthmatic hypertensive patients. Two comparison groups included patients with isolated asthma and isolated hypertension. All patients were genotyped for the NOS3 786C/T polymorphism. We measured total nitric oxide metabolites in their blood using a photocolorimetric technique and the Griess reagent. The levels of nitric oxide in the exhaled air were determined electrochemically using a portable NObreath monitor. The blood levels of nitric oxide metabolites amounted to 69.7 (60.0; 70.4) μmol/l in the CC genotype carriers, 68.9 (57.7; 77.4) μmol/l in the CT genotype carriers and 67.7 (59.7; 79.3) μmol/l in the patients with the TT genotype (p = 0.843). Individually, the groups demonstrated a clear association between the NOS3 786C/T polymorphism and the blood levels of nitric oxide metabolites. The patients with bronchial asthma and hypertension demonstrated a tendency to increasing nitric oxide levels following the pattern CC < CT < TT (p = 0.033 and p = 0.024, respectively). Thus, the C allele of the NOS3 786C/T polymorphism is associated with lower blood levels of nitric oxide metabolites in patients with bronchial asthma and hypertension.
VIEWS 4039